"My research focuses on the personalisation of medicine. In particular, I concentrate on the identification of biomarkers that help towards improved characterisation and more individual treatment of lung diseases. We have developed a blood test for patients with drug-resistant tuberculosis that can determine their individual length of treatment. Here in Kiel, within the Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI), we aim to expand research into, among other things, chronic inflammatory lung diseases and lung damage caused by COVID."
Jan Heyckendorf, 39 years old, born in Hamburg. Since January 2022: Professor of Pneumology specialising in chronic inflammatory lung diseases at Kiel University and acting director of the Leibniz-Lungenklinik (Leibniz lung clinic) at the University Medical Center Schleswig-Holstein (UKSH), Campus Kiel. Previously deputy medical director of the Medizinische Klinik (medical clinic) at Research Center Borstel – Leibniz Lung Center (FZB). 2011: Doctoral degree, 2019: Habilitation (postdoctoral lecture qualification) at the University of Lübeck.